Record Q2 Sales and Raised Guidance Power Astronics to $1.02B–$1.04B Outlook
ATRO has more than doubled off its 52-week low of $25.167.
Summary
Record Q2 2026 results featured a 27% sales jump to $260M, operating income of $40.5M, and a raised full-year revenue guide of $1.02B–$1.04B. A record backlog of $780.6M reinforces the bullish outlook.
Key Events · Earnings and Guidance · ATRO
-
Record Q2 Sales and Profitability
Driven by Aerospace strength, sales climbed 27% year-over-year to a record $260.0 million. Operating income surged to $40.5 million, yielding a 15.6% margin, while net income reached $35.1 million, or $0.75 per diluted share.
-
Raised 2026 Revenue Guidance
Full-year revenue guidance was lifted to $1.02–$1.04 billion, up from prior expectations, and Q3 revenue is guided to $265–$275 million, implying continued sequential growth.
-
Record Backlog and Bookings
Quarterly bookings hit a record $306.2 million, representing a book-to-bill of 1.18, and pushed backlog to a third consecutive record of $780.6 million. Approximately 82% of that backlog is expected to convert to revenue over the next twelve months.
-
Favorable UK Appeal Ruling Update
The UK Court of Appeal ruled in the company's favor in its patent dispute with Lufthansa Technik. Recovery of approximately $2.2 million in damages plus legal fees is expected in Q3 2026.
Analysis · ATRO · Manufacturing
A standout quarter saw revenue surge 27% to $260 million, operating margin expand to 15.6%, and adjusted EBITDA reach a multi-year high of $51.5 million. With record bookings and backlog, management raised the full-year revenue target to $1.02–$1.04 billion, underscoring confidence in sustained momentum. An additional tailwind comes from a favorable UK court ruling, which is expected to return approximately $2.2 million in damages during Q3. Trading near its 52-week high, the stock's premium valuation now looks well supported by these results.
At the time of this filing, ATRO was trading at $85.50 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $25.17 to $88.72. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.